Bibliographic Details
| Title: |
Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage |
| Authors: |
Woelders, E.C.I. a, 1, Yosofi, B. a, 1, Peeters, D.A.M. a, 1, Konijnenberg, L.S.F. a, 1, von Birgelen, C. b, 1, van Rees, J.B. c, 1, van den Oord, S.C.H. c, 1, Heestermans, A.A.C.M. d, 1, Claessen, B.E.P.M. e, 1, van Royen, N. a, 1, van Geuns, R.J.M. a, 1, Nijveldt, R. a, 1, Damman, P. a, ⁎, 1 |
| Source: |
In IJC Heart & Vasculature February 2025 56 |
| Database: |
ScienceDirect |
